Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 83 entries
Sorted by: Best Match Show Resources per page
Prof. Dr Med. Franciszek Groer.

Pediatria polska

REDLICH F.
PMID: 13504936
Pediatr Pol. 1957 May;32(5):465-73.

No abstract available.

Cite
REDLICH F. Prof. Dr Med. Franciszek Groër. Prof. Dr Med. Franciszek Groer. Pediatr Pol. 1957;32(5):465-73
REDLICH, F. (1957). Prof. Dr Med. Franciszek Groër. Prof. Dr Med. Franciszek Groer. Pediatria polska, 32(5), 465-73.
REDLICH, F. "Prof. Dr Med. Franciszek Groër." Prof. Dr Med. Franciszek Groer. Pediatria polska vol. 32,5 (1957): 465-73.
REDLICH F. Prof. Dr Med. Franciszek Groër. Prof. Dr Med. Franciszek Groer. Pediatr Pol. 1957 May;32(5):465-73. Polish. PMID: 13504936.
Copy Download .nbib Format: NLM
The evolution of emergency medicine.

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer

Edlich RF.
PMID: 21284593
J Environ Pathol Toxicol Oncol. 2010;29(4):271-91. doi: 10.1615/jenvironpatholtoxicoloncol.v29.i4.20.

In this manuscript, I will outline three specific evolutionary achievements in the delivery of emergency and trauma care, followed by caveats on what prevents an emergency and trauma system from achieving optimal goals and maintaining them. First, I will...

Cite
Edlich RF. The evolution of emergency medicine. J Environ Pathol Toxicol Oncol. 2010;29(4):271-91doi: 10.1615/jenvironpatholtoxicoloncol.v29.i4.20.
Edlich, R. F. (2010). The evolution of emergency medicine. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 29(4), 271-91. https://doi.org/10.1615/jenvironpatholtoxicoloncol.v29.i4.20
Edlich, Richard F. "The evolution of emergency medicine." Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer vol. 29,4 (2010): 271-91. doi: https://doi.org/10.1615/jenvironpatholtoxicoloncol.v29.i4.20
Edlich RF. The evolution of emergency medicine. J Environ Pathol Toxicol Oncol. 2010;29(4):271-91. doi: 10.1615/jenvironpatholtoxicoloncol.v29.i4.20. PMID: 21284593.
Copy Download .nbib Format: NLM
Polyelectrolyte multilayer surface functionalization of poly(dimethylsiloxane) (PDMS) for reduction of yeast cell adhesion in microfluidic devices.

Biomicrofluidics

Schmolke H, Demming S, Edlich A, Magdanz V, Büttgenbach S, Franco-Lara E, Krull R, Klages CP.
PMID: 21267092
Biomicrofluidics. 2010 Dec 29;4(4):44113. doi: 10.1063/1.3523059.

Polyelectrolyte multilayers (PEMs) based on the combinations poly(diallyldimethylammonium chloride)∕poly(acrylic acid) (PDADMAC∕PAA) and poly(allylamine hydrochloride)∕PAA (PAH∕PAA) were adsorbed on poly(dimethylsiloxane) (PDMS) and tested for nonspecific surface attachment of hydrophobic yeast cells using a parallel plate flow chamber. A custom-made graft...

Cite
Schmolke H, Demming S, Edlich A, et al. Polyelectrolyte multilayer surface functionalization of poly(dimethylsiloxane) (PDMS) for reduction of yeast cell adhesion in microfluidic devices. Biomicrofluidics. 2010;4(4):44113doi: 10.1063/1.3523059.
Schmolke, H., Demming, S., Edlich, A., Magdanz, V., Büttgenbach, S., Franco-Lara, E., Krull, R., & Klages, C. P. (2010). Polyelectrolyte multilayer surface functionalization of poly(dimethylsiloxane) (PDMS) for reduction of yeast cell adhesion in microfluidic devices. Biomicrofluidics, 4(4), 44113. https://doi.org/10.1063/1.3523059
Schmolke, Hannah, et al. "Polyelectrolyte multilayer surface functionalization of poly(dimethylsiloxane) (PDMS) for reduction of yeast cell adhesion in microfluidic devices." Biomicrofluidics vol. 4,4 (2010): 44113. doi: https://doi.org/10.1063/1.3523059
Schmolke H, Demming S, Edlich A, Magdanz V, Büttgenbach S, Franco-Lara E, Krull R, Klages CP. Polyelectrolyte multilayer surface functionalization of poly(dimethylsiloxane) (PDMS) for reduction of yeast cell adhesion in microfluidic devices. Biomicrofluidics. 2010 Dec 29;4(4):44113. doi: 10.1063/1.3523059. PMID: 21267092; PMCID: PMC3026037.
Copy Download .nbib Format: NLM
Tailoring gold nanostructures for near-field optical applications.

Nanotechnology

Fleischer M, Zhang D, Braun K, Jäger S, Ehlich R, Häffner M, Stanciu C, Hörber JK, Meixner AJ, Kern DP.
PMID: 20057031
Nanotechnology. 2010 Feb 10;21(6):065301. doi: 10.1088/0957-4484/21/6/065301. Epub 2010 Jan 08.

A method of combined thin-film deposition, electron beam lithography, and ion milling is presented for the fabrication of gold and silver nanostructures. The flexibility of lithographical processes for the variation of geometric parameters is combined with three-dimensional control over...

Cite
Fleischer M, Zhang D, Braun K, et al. Tailoring gold nanostructures for near-field optical applications. Nanotechnology. 2010;21(6):065301doi: 10.1088/0957-4484/21/6/065301.
Fleischer, M., Zhang, D., Braun, K., Jäger, S., Ehlich, R., Häffner, M., Stanciu, C., Hörber, J. K., Meixner, A. J., & Kern, D. P. (2010). Tailoring gold nanostructures for near-field optical applications. Nanotechnology, 21(6), 065301. https://doi.org/10.1088/0957-4484/21/6/065301
Fleischer, M, et al. "Tailoring gold nanostructures for near-field optical applications." Nanotechnology vol. 21,6 (2010): 065301. doi: https://doi.org/10.1088/0957-4484/21/6/065301
Fleischer M, Zhang D, Braun K, Jäger S, Ehlich R, Häffner M, Stanciu C, Hörber JK, Meixner AJ, Kern DP. Tailoring gold nanostructures for near-field optical applications. Nanotechnology. 2010 Feb 10;21(6):065301. doi: 10.1088/0957-4484/21/6/065301. Epub 2010 Jan 08. PMID: 20057031.
Copy Download .nbib Format: NLM
Correction: Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults.

Molecular psychiatry

Repple J, Karliczek G, Meinert S, Förster K, Grotegerd D, Goltermann J, Redlich R, Arolt V, Baune BT, Dannlowski U, Opel N.
PMID: 32203156
Mol Psychiatry. 2021 Apr;26(4):1409. doi: 10.1038/s41380-020-0710-z.

No abstract available.

Cite
Repple J, Karliczek G, Meinert S, et al. Correction: Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults. Mol Psychiatry. 2021;26(4):1409doi: 10.1038/s41380-020-0710-z.
Repple, J., Karliczek, G., Meinert, S., Förster, K., Grotegerd, D., Goltermann, J., Redlich, R., Arolt, V., Baune, B. T., Dannlowski, U., & Opel, N. (2021). Correction: Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults. Molecular psychiatry, 26(4), 1409. https://doi.org/10.1038/s41380-020-0710-z
Repple, Jonathan, et al. "Correction: Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults." Molecular psychiatry vol. 26,4 (2021): 1409. doi: https://doi.org/10.1038/s41380-020-0710-z
Repple J, Karliczek G, Meinert S, Förster K, Grotegerd D, Goltermann J, Redlich R, Arolt V, Baune BT, Dannlowski U, Opel N. Correction: Variation of HbA1c affects cognition and white matter microstructure in healthy, young adults. Mol Psychiatry. 2021 Apr;26(4):1409. doi: 10.1038/s41380-020-0710-z. PMID: 32203156.
Copy Download .nbib Format: NLM
Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group.

Human brain mapping

Ho TC, Gutman B, Pozzi E, Grabe HJ, Hosten N, Wittfeld K, Völzke H, Baune B, Dannlowski U, Förster K, Grotegerd D, Redlich R, Jansen A, Kircher T, Krug A, Meinert S, Nenadic I, Opel N, Dinga R, Veltman DJ, Schnell K, Veer I, Walter H, Gotlib IH, Sacchet MD, Aleman A, Groenewold NA, Stein DJ, Li M, Walter M, Ching CRK, Jahanshad N, Ragothaman A, Isaev D, Zavaliangos-Petropulu A, Thompson PM, Sämann PG, Schmaal L.
PMID: 32198905
Hum Brain Mapp. 2022 Jan;43(1):341-351. doi: 10.1002/hbm.24988. Epub 2020 Mar 21.

Alterations in regional subcortical brain volumes have been investigated as part of the efforts of an international consortium, ENIGMA, to identify reliable neural correlates of major depressive disorder (MDD). Given that subcortical structures are comprised of distinct subfields, we...

Cite
Ho TC, Gutman B, Pozzi E, et al. Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group. Hum Brain Mapp. 2020;43(1):341-351doi: 10.1002/hbm.24988.
Ho, T. C., Gutman, B., Pozzi, E., Grabe, H. J., Hosten, N., Wittfeld, K., Völzke, H., Baune, B., Dannlowski, U., Förster, K., Grotegerd, D., Redlich, R., Jansen, A., Kircher, T., Krug, A., Meinert, S., Nenadic, I., Opel, N., Dinga, R., Veltman, D. J., Schnell, K., Veer, I., Walter, H., Gotlib, I. H., Sacchet, M. D., Aleman, A., Groenewold, N. A., Stein, D. J., Li, M., Walter, M., Ching, C. R. K., Jahanshad, N., Ragothaman, A., Isaev, D., Zavaliangos-Petropulu, A., Thompson, P. M., Sämann, P. G., & Schmaal, L. (2022). Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group. Human brain mapping, 43(1), 341-351. https://doi.org/10.1002/hbm.24988
Ho, Tiffany C, et al. "Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group." Human brain mapping vol. 43,1 (2022): 341-351. doi: https://doi.org/10.1002/hbm.24988
Ho TC, Gutman B, Pozzi E, Grabe HJ, Hosten N, Wittfeld K, Völzke H, Baune B, Dannlowski U, Förster K, Grotegerd D, Redlich R, Jansen A, Kircher T, Krug A, Meinert S, Nenadic I, Opel N, Dinga R, Veltman DJ, Schnell K, Veer I, Walter H, Gotlib IH, Sacchet MD, Aleman A, Groenewold NA, Stein DJ, Li M, Walter M, Ching CRK, Jahanshad N, Ragothaman A, Isaev D, Zavaliangos-Petropulu A, Thompson PM, Sämann PG, Schmaal L. Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group. Hum Brain Mapp. 2022 Jan;43(1):341-351. doi: 10.1002/hbm.24988. Epub 2020 Mar 21. PMID: 32198905.
Copy Download .nbib Format: NLM
Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy.

Human brain mapping

Wade BSC, Hellemann G, Espinoza RT, Woods RP, Joshi SH, Redlich R, Dannlowski U, Jorgensen A, Abbott CC, Oltedal L, Narr KL.
PMID: 34390089
Hum Brain Mapp. 2021 Nov;42(16):5322-5333. doi: 10.1002/hbm.25620. Epub 2021 Aug 13.

Depression symptom heterogeneity limits the identifiability of treatment-response biomarkers. Whether improvement along dimensions of depressive symptoms relates to separable neural networks remains poorly understood. We build on work describing three latent symptom dimensions within the 17-item Hamilton Depression Rating...

Cite
Wade BSC, Hellemann G, Espinoza RT, et al. Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy. Hum Brain Mapp. 2021;42(16):5322-5333doi: 10.1002/hbm.25620.
Wade, B. S. C., Hellemann, G., Espinoza, R. T., Woods, R. P., Joshi, S. H., Redlich, R., Dannlowski, U., Jorgensen, A., Abbott, C. C., Oltedal, L., & Narr, K. L. (2021). Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy. Human brain mapping, 42(16), 5322-5333. https://doi.org/10.1002/hbm.25620
Wade, Benjamin S C, et al. "Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy." Human brain mapping vol. 42,16 (2021): 5322-5333. doi: https://doi.org/10.1002/hbm.25620
Wade BSC, Hellemann G, Espinoza RT, Woods RP, Joshi SH, Redlich R, Dannlowski U, Jorgensen A, Abbott CC, Oltedal L, Narr KL. Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy. Hum Brain Mapp. 2021 Nov;42(16):5322-5333. doi: 10.1002/hbm.25620. Epub 2021 Aug 13. PMID: 34390089; PMCID: PMC8519875.
Copy Download .nbib Format: NLM
"Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft

Harbrecht A, Endlich F, Hackl M, Seyboth K, Lethaus B, Müller LP, Wegmann K.
PMID: 34863911
Ann Anat. 2021 Dec 02;240:151878. doi: 10.1016/j.aanat.2021.151878. Epub 2021 Dec 02.

The aim of this study was to investigate whether life-like fractures of human cadaveric mandibles with a focus on the condylar process and the intact soft tissue envelope could be simulated. A total of nine fresh-frozen human head specimens...

Cite
Harbrecht A, Endlich F, Hackl M, et al. "Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery. Ann Anat. 2021;240:151878doi: 10.1016/j.aanat.2021.151878.
Harbrecht, A., Endlich, F., Hackl, M., Seyboth, K., Lethaus, B., Müller, L. P., & Wegmann, K. (2021). "Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft, 240151878. https://doi.org/10.1016/j.aanat.2021.151878
Harbrecht, Andreas, et al. ""Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery." Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft vol. 240 (2021): 151878. doi: https://doi.org/10.1016/j.aanat.2021.151878
Harbrecht A, Endlich F, Hackl M, Seyboth K, Lethaus B, Müller LP, Wegmann K. "Crack under pressure"-Inducing life-like mandible fractures as a potential benefit to surgical education in oral and maxillofacial surgery. Ann Anat. 2021 Dec 02;240:151878. doi: 10.1016/j.aanat.2021.151878. Epub 2021 Dec 02. PMID: 34863911.
Copy Download .nbib Format: NLM
Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender women.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Flint C, Förster K, Koser SA, Konrad C, Zwitserlood P, Berger K, Hermesdorf M, Kircher T, Nenadic I, Krug A, Baune BT, Dohm K, Redlich R, Opel N, Arolt V, Hahn T, Jiang X, Dannlowski U, Grotegerd D.
PMID: 34707249
Neuropsychopharmacology. 2022 Jan;47(2):611. doi: 10.1038/s41386-021-01203-2.

No abstract available.

Cite
Flint C, Förster K, Koser SA, et al. Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender women. Neuropsychopharmacology. 2022;47(2):611doi: 10.1038/s41386-021-01203-2.
Flint, C., Förster, K., Koser, S. A., Konrad, C., Zwitserlood, P., Berger, K., Hermesdorf, M., Kircher, T., Nenadic, I., Krug, A., Baune, B. T., Dohm, K., Redlich, R., Opel, N., Arolt, V., Hahn, T., Jiang, X., Dannlowski, U., & Grotegerd, D. (2022). Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender women. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 47(2), 611. https://doi.org/10.1038/s41386-021-01203-2
Flint, Claas, et al. "Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender women." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 47,2 (2022): 611. doi: https://doi.org/10.1038/s41386-021-01203-2
Flint C, Förster K, Koser SA, Konrad C, Zwitserlood P, Berger K, Hermesdorf M, Kircher T, Nenadic I, Krug A, Baune BT, Dohm K, Redlich R, Opel N, Arolt V, Hahn T, Jiang X, Dannlowski U, Grotegerd D. Correction to: Biological sex classification with structural MRI data shows increased misclassification in transgender women. Neuropsychopharmacology. 2022 Jan;47(2):611. doi: 10.1038/s41386-021-01203-2. PMID: 34707249.
Copy Download .nbib Format: NLM
The price of research neglect.

The American journal of psychiatry

Holzman PS, Redlich F.
PMID: 6847989
Am J Psychiatry. 1983 Jan;140(1):73-4. doi: 10.1176/ajp.140.1.73.

No abstract available.

Cite
Holzman PS, Redlich F. The price of research neglect. Am J Psychiatry. 1983;140(1):73-4doi: 10.1176/ajp.140.1.73.
Holzman, P. S., & Redlich, F. (1983). The price of research neglect. The American journal of psychiatry, 140(1), 73-4. https://doi.org/10.1176/ajp.140.1.73
Holzman, P S, and Redlich, F. "The price of research neglect." The American journal of psychiatry vol. 140,1 (1983): 73-4. doi: https://doi.org/10.1176/ajp.140.1.73
Holzman PS, Redlich F. The price of research neglect. Am J Psychiatry. 1983 Jan;140(1):73-4. doi: 10.1176/ajp.140.1.73. PMID: 6847989.
Copy Download .nbib Format: NLM
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial.

JAMA oncology

Rugo HS, Im SA, Cardoso F, Cortés J, Curigliano G, Musolino A, Pegram MD, Wright GS, Saura C, Escrivá-de-Romaní S, De Laurentiis M, Levy C, Brown-Glaberman U, Ferrero JM, de Boer M, Kim SB, Petráková K, Yardley DA, Freedman O, Jakobsen EH, Kaufman B, Yerushalmi R, Fasching PA, Nordstrom JL, Bonvini E, Koenig S, Edlich S, Hong S, Rock EP, Gradishar WJ.
PMID: 33480963
JAMA Oncol. 2021 Apr 01;7(4):573-584. doi: 10.1001/jamaoncol.2020.7932.

IMPORTANCE: ERRB2 (formerly HER2)-positive advanced breast cancer (ABC) remains typically incurable with optimal treatment undefined in later lines of therapy. The chimeric antibody margetuximab shares ERBB2 specificity with trastuzumab but incorporates an engineered Fc region to increase immune activation.OBJECTIVE:...

Cite
Rugo HS, Im SA, Cardoso F, et al. Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021;7(4):573-584doi: 10.1001/jamaoncol.2020.7932.
Rugo, H. S., Im, S. A., Cardoso, F., Cortés, J., Curigliano, G., Musolino, A., Pegram, M. D., Wright, G. S., Saura, C., Escrivá-de-Romaní, S., De Laurentiis, M., Levy, C., Brown-Glaberman, U., Ferrero, J. M., de Boer, M., Kim, S. B., Petráková, K., Yardley, D. A., Freedman, O., Jakobsen, E. H., Kaufman, B., Yerushalmi, R., Fasching, P. A., Nordstrom, J. L., Bonvini, E., Koenig, S., Edlich, S., Hong, S., Rock, E. P., Gradishar, W. J. (2021). Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial. JAMA oncology, 7(4), 573-584. https://doi.org/10.1001/jamaoncol.2020.7932
Rugo, Hope S, et al. "Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial." JAMA oncology vol. 7,4 (2021): 573-584. doi: https://doi.org/10.1001/jamaoncol.2020.7932
Rugo HS, Im SA, Cardoso F, Cortés J, Curigliano G, Musolino A, Pegram MD, Wright GS, Saura C, Escrivá-de-Romaní S, De Laurentiis M, Levy C, Brown-Glaberman U, Ferrero JM, de Boer M, Kim SB, Petráková K, Yardley DA, Freedman O, Jakobsen EH, Kaufman B, Yerushalmi R, Fasching PA, Nordstrom JL, Bonvini E, Koenig S, Edlich S, Hong S, Rock EP, Gradishar WJ. Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021 Apr 01;7(4):573-584. doi: 10.1001/jamaoncol.2020.7932. PMID: 33480963; PMCID: PMC7823434.
Copy Download .nbib Format: NLM
Brain functional correlates of emotional face processing in body dysmorphic disorder.

Journal of psychiatric research

Borgers T, Kürten M, Kappelhoff A, Enneking V, Möllmann A, Schulte J, Klug M, Leehr EJ, Dohm K, Grotegerd D, Krause P, Zwiky E, Dannlowski U, Buhlmann U, Redlich R.
PMID: 35030511
J Psychiatr Res. 2022 Jan 07;147:103-110. doi: 10.1016/j.jpsychires.2022.01.007. Epub 2022 Jan 07.

Previous neuroimaging studies in body dysmorphic disorder (BDD) have focused on discordances in visual processing systems. However, little is known about brain functional aberrations in individuals with BDD during emotional face processing. An fMRI paradigm with negative emotional faces...

Cite
Borgers T, Kürten M, Kappelhoff A, et al. Brain functional correlates of emotional face processing in body dysmorphic disorder. J Psychiatr Res. 2022;147:103-110doi: 10.1016/j.jpsychires.2022.01.007.
Borgers, T., Kürten, M., Kappelhoff, A., Enneking, V., Möllmann, A., Schulte, J., Klug, M., Leehr, E. J., Dohm, K., Grotegerd, D., Krause, P., Zwiky, E., Dannlowski, U., Buhlmann, U., & Redlich, R. (2022). Brain functional correlates of emotional face processing in body dysmorphic disorder. Journal of psychiatric research, 147103-110. https://doi.org/10.1016/j.jpsychires.2022.01.007
Borgers, Tiana, et al. "Brain functional correlates of emotional face processing in body dysmorphic disorder." Journal of psychiatric research vol. 147 (2022): 103-110. doi: https://doi.org/10.1016/j.jpsychires.2022.01.007
Borgers T, Kürten M, Kappelhoff A, Enneking V, Möllmann A, Schulte J, Klug M, Leehr EJ, Dohm K, Grotegerd D, Krause P, Zwiky E, Dannlowski U, Buhlmann U, Redlich R. Brain functional correlates of emotional face processing in body dysmorphic disorder. J Psychiatr Res. 2022 Jan 07;147:103-110. doi: 10.1016/j.jpsychires.2022.01.007. Epub 2022 Jan 07. PMID: 35030511.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 83 entries